Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 4
Author(s): S.M. Nabavi
Affiliation:
Export Options
About this article
Cite this article as:
Nabavi S.M. , Meet Our Editorial Board Member, Current Neuropharmacology 2020; 18 (4) . https://dx.doi.org/10.2174/1570159X1804200302111549
DOI https://dx.doi.org/10.2174/1570159X1804200302111549 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
17
1
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Amyloid β-Peptide [1-42]-Associated Free Radical-Induced Oxidative Stress And Neurodegeneration in Alzheimers Disease Brain: Mechanisms and Consequences
Current Medicinal Chemistry Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma
Current Medicinal Chemistry Intraocular Immune Mechanisms in Uveitis
Current Immunology Reviews (Discontinued) Brain Angiotensin II Involvement in Chronic Mental Disorders
Protein & Peptide Letters PACAP is Implicated in the Stress Axes
Current Pharmaceutical Design Review: Involvement of the Cavum Septi Pellucidi and the Fornix in the Neuropathology of Schizophrenia and Affective Disorders
Current Psychiatry Reviews Acute and Chronic Treatments with Quetiapine Increase Mitochondrial Respiratory Chain Complex Activity in the Rat Brain
Current Neurovascular Research Psychological Perspectives of Inflammatory Bowel Disease Patients Undergoing Surgery: Rightful Concerns and Preconceptions
Current Drug Targets Early Ischemic Blood Brain Barrier Damage: A Potential Indicator for Hemorrhagic Transformation Following Tissue Plasminogen Activator (tPA) Thrombolysis?
Current Neurovascular Research Meet the Editorial Board
Current Alzheimer Research Resistant TB: Newer Drugs and Community Approach
Recent Patents on Anti-Infective Drug Discovery Neck Circumference and its Correlation to Other Anthropometric Parameters and Finnish Diabetes Risk Score (FINDRISC)
Current Diabetes Reviews HDL Therapy: Two Kinds of Right?
Current Pharmaceutical Design Selective Divalent Copper Chelation for the Treatment of Diabetes Mellitus
Current Medicinal Chemistry Copy Number Variations with Isolated Fetal Ventriculomegaly
Current Molecular Medicine Receptors and Enzymes for Medical Sensing of L-Glutamate
Mini-Reviews in Medicinal Chemistry Association Constants of Pyridine and Piperidine Alkaloids to Amyloid ß Peptide Determined by Electrochemical Impedance Spectroscopy
Current Alzheimer Research The Radiosensitizing Effect of Olanzapine as an Antipsychotic Medication on Glioblastoma Cell
Current Radiopharmaceuticals Thrombolytic Agents for Acute Ischaemic Stroke Treatment: The Past, Present and Future
CNS & Neurological Disorders - Drug Targets Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases
Current Protein & Peptide Science